High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: A randomized study

Annals of Hematology

Volumn 89, Issue 6, 2010, Pages 591-596

  Balduini, Carlo L ^a   Gugliotta, Luigi ^b   Luppi, Mario ^c   Laurenti, Luca ^d   Klersy, Catherine ^a   Pieresca, Carla ^a   Quintini, Gerlando ^e   Iuliano, Francesco ^f   Re, Rossana ^g   Spedini, Pierangelo ^h   Vianelli, Nicola ⁱ   Zaccaria, Alfonso ^j   Pogliani, Enrico Maria ^k   Musso, Roberto ^l   Bobbio Pallavicini, Enrico ^m   Quarta, Giovanni ⁿ   Galieni, Piero ^o   Fragasso, Alberto ^p   Casella, Gianluca ^a   Noris, Patrizia ^a   Ascari, Edoardo ^a   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f Giannettasio Hospital   (Italy)

^g Civitanova Marche Hospital   (Italy)

^h CREMONA HOSPITAL   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j Ravenna Hospital   (Italy)

^k SAN GERARDO HOSPITAL   (Italy)

^l Ferrarotto Hospital   (Italy)

^m Crema Hospital   (Italy)

ⁿ A Perrino Hospital   (Italy)

^o Ospedale Mazzoni   (Italy)

^p MADONNA DELLE GRAZIE HOSPITAL   (Italy)

more..

Author keywords

Plasma exchange; Steroids; Thrombocytopenia; TTP

Indexed keywords

CORTICOSTEROID DERIVATIVE; FRESH FROZEN PLASMA; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME; ACUTE PHASE RESPONSE; DOSE RESPONSE; IMMUNOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL;

ACUTE-PHASE REACTION; ADULT; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77951650730     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0877-5     Document Type: Article

References (24)

1. RM Bukowski JW King JS Hewlett 1977 Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura Blood 50 413 417 1:STN:280: DyaE2s3it1GjtQ%3D%3D 560229
2. JJ Byrnes M Khurana 1977 Treatment of thrombotic thrombocytopenic purpura with plasma N Engl J Med 297 1386 1389 1:STN:280:DyaE1c%2FltV2rsw%3D%3D 562982
3. GA Rock KH Shumak NA Buskard VS Blanchette JG Kelton RC Nair RA Spasoff 1991 Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group N Engl J Med 325 393 397 1:STN:280:DyaK3M3oslOnug%3D%3D 2062330
4. M Furlan R Robles M Galbusera G Remuzzi PA Kyrle B Brenner M Krause I Scharrer V Aumann U Mittler M Solenthaler B Lammle 1998 von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1578 1584 10.1056/NEJM199811263392202 1:STN:280:DyaK1M%2Fjt1Sgsg%3D%3D 9828245 (Pubitemid 28536132)
5. JN George 2006 Clinical practice. Thrombotic thrombocytopenic purpura N Engl J Med 354 1927 1935 10.1056/NEJMcp053024 1:CAS:528:DC%2BD28XksVGiurk%3D 16672704 (Pubitemid 43872694)
6. SL Allford BJ Hunt P Rose SJ Machin Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology 2003 Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias Br J Haematol 120 556 573 10.1046/j.1365-2141.2003.04049.x 12588343
7. G Rock KH Shumak DM Sutton NA Buskard RC Nair 1996 Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura Br J Haematol 94 383 386 10.1046/j.1365-2141.1996.d01-1800.x 1:STN:280: DyaK28zis1antg%3D%3D 8759902
8. G Rock D Anderson W Clark P Leblond D Palmer M Sternbach D Sutton G Wells 2005 Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet Br J Haematol 129 79 86 10.1111/j.1365-2141.2005.05418.x 1:CAS:528:DC%2BD2MXktVCgtrs%3D 15801959 (Pubitemid 40524055)
9. E Bobbio-Pallavicini L Gugliotta R Centurioni C Porta N Vianelli A Billio F Tacconi E Ascari 1997 Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP Haematologica 82 429 435 1:CAS:528:DyaK2sXntlOis7s%3D 9299856
10. PD Mintz A Neff M MacKenzie LT Goodnough C Hillyer C Kessler K McCrae JE Menitove BS Skikne L Damon I Lopez-Plaza C Rouault KP Crookston RJ Benjamin J George JS Lin L Corash MG Conlan 2006 A randomized, controlled phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura Transfusion 46 1693 1704 10.1111/j.1537-2995.2006. 00959.x 1:CAS:528:DC%2BD28Xht1SqsLzE 17002625 (Pubitemid 44435721)
11. SR Cataland M Jin AK Ferketich MS Kennedy EH Kraut JN George HM Wu 2007 An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura Br J Haematol 136 146 149 10.1111/j.1365-2141.2006.06384.x 1:CAS:528: DC%2BD2sXisVKit78%3D 17069579 (Pubitemid 44912601)
12. WR Bell HG Braine PM Ness TS Kickler 1991 Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients N Engl J Med 325 398 403 1:STN:280:DyaK3M3oslOnuw%3D%3D 2062331
13. P Rojnuckarin P Watanaboonyongcharoen B Akkawat T Intragumtornchai 2006 The role of pulse dexamethasone in acquired idiopathic thrombotic thrombocytopenic purpura J Thromb Haemost 4 1148 1150 10.1111/j.1538-7836.2006. 01879.x 1:STN:280:DC%2BD283msFyqtA%3D%3D 16689774
14. M Toyoshige Y Zaitsu K Okafuji Y Inoue Y Hiroshige N Matsumoto K Kaku T Kaneko 1992 Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid Am J Hematol 41 69 10.1002/ajh.2830410119 1:STN:280:DyaK38zmslOlsQ%3D%3D 1503108
15. S Shariatmadar M Nassiri V Vincek 2005 Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura Am J Hematol 79 83 88 10.1002/ajh.20342 1:CAS:528:DC%2BD2MXls1GisL8%3D 15929111 (Pubitemid 40770665)
16. SR Cataland M Jin S Lin MS Kennedy EH Kraut JN George HM Wu 2007 Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity Br J Haematol 139 486 493 1:CAS:528:DC%2BD2sXhtlOhtL%2FP 17910638
17. Y Mori H Wada EC Gabazza N Minami T Nobori H Shiku H Yagi H Ishizashi M Matsumoto Y Fujimura 2002 Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity Transfusion 42 572 580 10.1046/j.1537-2995.2002.00100.x 1:CAS:528:DC%2BD38Xlt1Kgs7w%3D 12084165
18. P Coppo D Bengoufa A Veyradier M Wolf A Bussel GA Millot S Malot F Heshmati JP Mira E Boulanger L Galicier MA Durey-Dragon V Frémeaux-Bacchi M Ramakers A Pruna D Bordessoule V Gouilleux ML Scrobohaci JP Vernant D Moreau E Azoulay B Schlemmer L Guillevin K Lassoued 2004 Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement Medicine (Baltimore) 83 233 244 10.1097/01.md.0000133622. 03370.07 1:CAS:528:DC%2BD2cXltlOkurc%3D (Pubitemid 38955446)
19. P Coppo D Bengoufa A Veyradier M Wolf A Bussel GA Millot S Malot F Heshmati JP Mira E Boulanger L Galicier MA Durey-Dragon V Frémeaux-Bacchi M Ramakers A Pruna D Bordessoule V Gouilleux ML Scrobohaci JP Vernant D Moreau E Azoulay B Schlemmer L Guillevin K Lassoued 2005 Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura Br J Haematol 132 66 74 10.1111/j.1365-2141.2005.05837.x
20. M Böhm C Betz W Miesbach M Krause C von Auer H Geiger I Scharrer 2005 The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine Br J Haematol 129 644 652 10.1111/j.1365-2141.2005.05512.x 15916687 (Pubitemid 40825826)
21. Mannucci PM, Peyvandi F (2007) TTP and ADAMTS13: when is testing appropriate? Hematology Am Soc Hematol Educ Program 121-126
22. S Ferrari F Scheiflinger M Rieger G Mudde M Wolf P Coppo JP Girma E Azoulay C Brun-Buisson F Fakhouri JP Mira E Oksenhendler P Poullin E Rondeau N Schleinitz B Schlemmer JL Teboul P Vanhille JP Vernant D Meyer A Veyradier 2007 Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity Blood 109 2815 2822 1:CAS:528:DC%2BD2sXjvVyns70%3D 17164349
23. M Jin TC Casper SR Cataland MS Kennedy S Lin YJ Li HM Wu 2008 Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse Br J Haematol 141 651 658 10.1111/j.1365-2141.2008.07107.x 1:CAS:528:DC%2BD1cXotVaqsL4%3D 18397340 (Pubitemid 351667632)
24. F Peyvandi S Lavoretano R Palla HB Feys K Vanhoorelbeke T Battaglioli C Valsecchi MT Canciani F Fabris S Zver M Réti D Mikovic M Karimi G Giuffrida L Laurenti PM Mannucci 2008 ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission Haematologica 93 232 239 10.3324/haematol.11739 1:CAS:528: DC%2BD1cXhsVSiu7zJ 18223285 (Pubitemid 351397711)